Shelton Wealth Management’s Astera Labs ALAB Stock Holding History

Shelton Wealth Management’s Portfolio ALAB Stock Details ALAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-500	Closed	-$83.2K	–	185
2025 Q4	$83.2K	Buy	+500	New	+$83.6K	0.04%	148

Other funds holding ALAB

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Atreides Management Boston, Massachusetts $5B AUM 78.34% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

Shelton Wealth Management's ALAB Position: Q1 2026 in Review

Shelton Wealth Management sold out of Astera Labs (ALAB) in Q1 2026, closing a stake of 5,154 shares — an estimated $857K sold.

Shelton Wealth Management first reported a position in ALAB in Q4 2025 and held it in 1 quarter. The position peaked at $857K in Q4 2025. 704 funds tracked by Wall St. Rank hold ALAB as of Q1 2026.

Shelton Wealth Management reported no remaining Astera Labs position as of Q1 2026 after selling out during the quarter.
Shelton Wealth Management sold 5,154 Astera Labs shares in Q1 2026, an estimated $857K.
Shelton Wealth Management first reported a position in Astera Labs in Q4 2025 and held it in 1 quarter.
Shelton Wealth Management's Astera Labs position peaked at $857K in Q4 2025.
704 funds tracked by Wall St. Rank held Astera Labs as of Q1 2026.

Based on Shelton Wealth Management's 13F filing for Q1 2026, filed 28 Apr 2026.